Cerecor Inc. (NASDAQ:CERC) Director Armistice Capital, Llc acquired 35,200 shares of the company’s stock in a transaction dated Wednesday, November 22nd. The stock was purchased at an average cost of $1.20 per share, for a total transaction of $42,240.00. The purchase was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Armistice Capital, Llc also recently made the following trade(s):

  • On Friday, November 24th, Armistice Capital, Llc bought 10,000 shares of Cerecor stock. The shares were bought at an average cost of $1.20 per share, for a total transaction of $12,000.00.
  • On Wednesday, September 20th, Armistice Capital, Llc bought 15,250 shares of Cerecor stock. The shares were bought at an average cost of $0.76 per share, for a total transaction of $11,590.00.
  • On Tuesday, September 19th, Armistice Capital, Llc bought 30,119 shares of Cerecor stock. The shares were bought at an average cost of $0.74 per share, for a total transaction of $22,288.06.
  • On Monday, September 18th, Armistice Capital, Llc bought 6,000 shares of Cerecor stock. The shares were bought at an average cost of $0.78 per share, for a total transaction of $4,680.00.
  • On Friday, September 8th, Armistice Capital, Llc bought 2,060 shares of Cerecor stock. The shares were bought at an average cost of $0.75 per share, for a total transaction of $1,545.00.
  • On Wednesday, September 6th, Armistice Capital, Llc purchased 2,239 shares of Cerecor stock. The shares were acquired at an average price of $0.74 per share, for a total transaction of $1,656.86.
  • On Friday, September 1st, Armistice Capital, Llc purchased 13,867 shares of Cerecor stock. The shares were acquired at an average price of $0.73 per share, for a total transaction of $10,122.91.
  • On Thursday, August 31st, Armistice Capital, Llc purchased 25,100 shares of Cerecor stock. The shares were acquired at an average price of $0.77 per share, for a total transaction of $19,327.00.
  • On Wednesday, August 30th, Armistice Capital, Llc purchased 512 shares of Cerecor stock. The shares were acquired at an average price of $0.74 per share, for a total transaction of $378.88.

Shares of Cerecor Inc. (CERC) opened at $1.18 on Monday. The stock has a market capitalization of $30.74, a PE ratio of 118.00 and a beta of 2.13. Cerecor Inc. has a 52 week low of $0.34 and a 52 week high of $5.57.

A number of research analysts have commented on CERC shares. ValuEngine upgraded Cerecor from a “strong sell” rating to a “sell” rating in a research note on Tuesday, November 7th. TheStreet upgraded Cerecor from an “e+” rating to a “c-” rating in a research note on Wednesday, November 8th.

COPYRIGHT VIOLATION NOTICE: This report was originally published by Daily Political and is the sole property of of Daily Political. If you are reading this report on another website, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright legislation. The legal version of this report can be read at https://www.dailypolitical.com/2017/11/27/insider-buying-cerecor-inc-cerc-director-acquires-42240-00-in-stock-2.html.

About Cerecor

Cerecor, Inc is a clinical stage biopharmaceutical company. The Company is engaged in developing drug candidates for patients with neurological and psychiatric disorders. The Company has a portfolio of clinical and preclinical compounds that it is developing for a range of indications, including CERC-301, which is an adjunctive treatment for major depressive disorder (MDD); CERC-501, which is for substance use disorders and adjunctive treatment of MDD, and CERC-406, which is for the treatment of cognitive impairment.

Insider Buying and Selling by Quarter for Cerecor (NASDAQ:CERC)

Receive News & Ratings for Cerecor Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerecor Inc. and related companies with MarketBeat.com's FREE daily email newsletter.